Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Arena Pharmaceuticals, Inc. and Aristea Therapeutics, Inc. announced a strategic collaboration to advance the clinical...
Arena Pharmaceuticals’ Strategic Collaboration with Aristea Therapeutics
Thoma Bravo’s $6.4 Billion Acquisition of Medallia
Wilson Sonsini Goodrich & Rosati advised Medallia on the deal. Latham & Watkins represented Blackstone Alternative Credit Advisors as the lead lender, as well as credit arms...
Aurora’s Merger With Reinvent Technology Partners Y
Wilson Sonsini Goodrich & Rosati, P.C. acted as legal counsel to Aurora, while Skadden, Arps, Slate, Meagher & Flom LLP advised Reinvent. Sullivan & Cromwell LLP...
Gopuff’s Acquisition of RideOS
Wilson Sonsini Goodrich & Rosati advised rideOS on the deal. Gopuff, the go-to solution for immediate everyday needs, announced that it has entered into an agreement...
Symphony Technology Group’s $1.2 Billion Acquisition of FireEye Products Business
Paul Hastings LLP advised Symphony Technology Group on the deal while Wilson Sonsini Goodrich & Rosati represented FireEye. Symphony Technology Group, a private equity firm focused...
Everlywell’s Acquisition of PWNHealth and Home Access Health Corporation
Wilson Sonsini Goodrich & Rosati advised Everlywell on the deal, while Choate represented PWNHealth. Everlywell, a leading digital health company, announced that it has acquired PWNHealth...
Spire Global’s Merger with NavSight Holdings
Wilson Sonsini Goodrich & Rosat advised Spire Global, Inc. on the deal. Spire Global, Inc., a global provider of space-based data and analytics, and NavSight Holdings...